Navigation Links
IDM Pharma Reports 2007 Financial Results
Date:3/20/2008

IRVINE, Calif., March 20 /PRNewswire-FirstCall/ -- IDM Pharma, Inc. (Nasdaq: IDMI) today reported financial results for the fourth quarter and full year ended December 31, 2007. Financial information presented represents the consolidated results of IDM Pharma, Inc. and its subsidiary, IDM Pharma S.A.

Total revenues in the quarter ended December 31, 2007 were $5.6 million, and net loss was $2.7 million or $0.11 per share for the quarter. Total revenues for the year ended December 31, 2007 were $14.6 million, and net loss was $18.3 million or $0.87 per share for the year. Revenues in both the quarter and year ended December 31, 2007 included $2.4 million of deferred revenue recognized by the Company as a result of the decision by sanofi-aventis to terminate its participation in the UVIDEM development program in December 2007. Cash and cash equivalents was $28.4 million as of December 31, 2007 compared to $33.2 million on September 30, 2007 and $10.2 million on December 31, 2006. We believe that our existing cash resources are sufficient to meet our cash requirements, based on our current development and operating plan, into the first half of 2009.

Business Highlights

-- The European Committee for Medicinal Products for Human Use, or CHMP,

determined in a non-binding opinion in late January 2008 that

L-MTP-PE suggested a possible clinical benefit in terms of survival

and granted the Company a clock stop, or time extension.

-- The Company expects to receive a final opinion regarding L-MTP-PE from

the CHMP in the third quarter of 2008 and a final decision from the

European Commission in the fourth quarter of 2008.

-- The Company expects to file an amend
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Anemia and tropical diseases; Is pharmacogenomics ready for the clinic?
2. Mylan Commences Tender Offers and Consent Solicitations for Its 5.750% Senior Notes Due 2010 and 6.375% Senior Notes Due 2015 in Connection With Its Proposed Acquisition of Mercks Generic Pharmaceutical Business
3. Arena Pharmaceuticals to Present at the NewsMakers in the Biotech Industry Conference
4. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Zyloprim(R)
5. The Pharma & Life Sciences Best Practice Database: an Industry Resource for Successful Techniques and Performance Benchmarks for Reaching the Top
6. Schering-Plough/Merck Pharmaceuticals Announce FDA Filing Acceptance of New Drug Application for Loratadine/Montelukast Tablet
7. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Adipex-P(R)
8. National Pharmaceutical Council Announces New Strategic Focus, Search for New Leadership
9. AKELA Pharma Inc. announces positive results for the extension part of its Phase IIb Fentanyl TAIFUN(R) trial
10. Caraco Pharmaceutical Laboratories, Ltd. Announces FDA Approval to Market Generic Version of Coreg(R)
11. Innocoll Agrees the Sale of its CollaRx(R) GENTAMICIN SURGICAL IMPLANT and European Sales and Marketing Infrastructure to EUSA Pharma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/31/2014)... 2014 The Memory Healer review published by ... Lynch, whose father suffered from Alzheimer's disease. , In ... by his father's disease. His father pointed a gun and ... moment when the author of this method understood that he ... The Memory Healer program is based on years of research. ...
(Date:10/31/2014)... 31, 2014 This Method to ... health effects for practitioners. , The Hypopresive ... of Science and Movement specializing in physical rehabilitation. ... pelvic floor reeducation that traditional abdominal exercises after ... Recti, Prolepses, etc. , The Hipopressives exercises pull ...
(Date:10/31/2014)... City, UT (PRWEB) October 31, 2014 ... the new Activz Silver line offering natural ... cleansing wipes. For over a century, silver has been ... found in Activz Silver products is the most advanced ... patents, has a unique chemical structure that supports the ...
(Date:10/31/2014)... Oct. 31, 2014 (HealthDay News) -- Sleep apnea may make ... where you parked your car or left your house keys, ... severe sleep apnea showed that this ability -- called spatial ... movement (REM) sleep, even when other stages of sleep weren,t ... which dreams typically occur. "We,ve shown for the first ...
(Date:10/31/2014)... – New research suggests that insomnia is a major ... other unintentional fatal injuries. The results underscore the importance ... National Healthy Sleep Awareness Project. , Results show that ... dose-dependent manner with the number of insomnia symptoms present. ... times more likely to die from a fatal injury ...
Breaking Medicine News(10 mins):Health News:"Memory Healer" Review Reveals a New Natural Remedy Guide for Managing Memory Loss 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 2Health News:Super Models and European Celebrities’ Secret Flat Tummy System Comes to America 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 2Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 3Health News:New Collection of Nano-particle Natural Silver Products by Activz Whole-Food Nutrition 4Health News:Sleep Apnea May Steal Some of Your Memory: Study 2Health News:Insomnia increases risk of motor vehicle deaths, other fatal injuries 2
... Zealander says that he was forced to take dramatic action in ... medications. // He says the local DHB began trying to get ... from the hospital unless provided with the drug. ,Joanne ... controls her nausea. The Hawke's Bay hospital refused to provide enough ...
... takes a bad turn when the Texas jury awarded $32 million ... consuming the painkiller Vioxx. // But this will be greatly reduced ... a weak case against Vioxx maker Merck & Co. Inc. ... in compensatory damages for mental anguish and personal loss and $25 ...
... published in the Journal of Neurology, Neurosurgery and Psychiatry highlights ... Alzheimer’s disease after being exposed to high levels of aluminum ... when she died in 2004. ,Chris Exley, of Keele ... been directly linked to the 20 tonnes of aluminum sulphate, ...
... for Disease Control and Prevention (CDC) it was noted that a ... the month of May, June and July. // ,Hence ... tick bites. Statistics show that the number of cases of Lyme ... 2005. U.S. CDC reports that Lyme disease is greatly underreported. It ...
... caspase-12, touted as the wonder enzyme in sepsis increases ... while a deficiency confers strong resistance to sepsis. // ... innate immunity in humans. ,"The results of ... role in the elimination of bacterial pathogens, and that ...
... Kevin Gosling donated a part of his liver to a 5-year ... disease //. He further stated that he had no regrets about ... own life at risk, adding that he would do it again, ... one of his family friends is said to have been instrumental ...
Cached Medicine News:Health News:Merck in the Dock Due To Vioxx 2Health News:Exposure To High Aluminum Levels In Tap Water Lead To Rare Form Of Alzheimers 2Health News:Sepsis risk increased due to the absence of one key enzyme 2Health News:46-Year-Old Canada Man Donates A Part Of His Liver To A Complete Stranger 2
(Date:10/31/2014)... Imago BioSciences, Inc., a biotech company ... Series A financing led by Clarus Ventures LLC, ... of accomplished investment and operating professionals dedicated to ... include Frazier Healthcare, Amgen Ventures, and Merck Research ... Frazier Healthcare will join the company,s board of ...
(Date:10/31/2014)... 2014  Lycera Corp., a biopharmaceutical company developing ... and cancer, today announced that data on the ... candidates will be presented at the annual meeting ... being held November 6-9, 2014 at the Gaylord ...  The poster, entitled " Novel synthetic RORgamma agonist ...
(Date:10/31/2014)... LONDON , October 31, 2014 ... Nanosphere Inc. (NASDAQ: NSPH ), Isis Pharmaceuticals ... (NASDAQ: HALO ), ACADIA Pharmaceuticals Inc. (NASDAQ: ... SNTA). Free research on these five companies can be ... October 30, 2014, the NASDAQ Composite ended at 4,566.14, ...
Breaking Medicine Technology:Imago BioSciences Announces $26.5 Million Financing Led by Clarus Ventures 2Lycera Announces Presentation of Data on Anti-Tumor Activity of Novel Synthetic RORgamma Agonists at Society for Immunotherapy of Cancer Meeting 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 2Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 3Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 4Momentum Indicators for Biotech Stocks -- Nanosphere, Isis Pharma, Halozyme Therapeutics, ACADIA Pharma, and Synta Pharma 5
... 7, 2011 MinuteClinic, the retail health ... ), has entered into a clinical affiliation with Advocate ... high quality, affordable health care services provided to patients ... the largest clinical collaboration between a regional health system ...
... AUSTIN, Texas, April 7, 2011 Ascension Orthopedics, Inc., ... implantations of the TITAN Modular Total Shoulder.  The surgeries ... Hospital in Baltimore, MD.     "I ... a number of years in my practice. Now that ...
Cached Medicine Technology:New Affiliation Between MinuteClinic and Advocate Health Care Increases Access to Medical Services in Chicagoland 2New Affiliation Between MinuteClinic and Advocate Health Care Increases Access to Medical Services in Chicagoland 3New Affiliation Between MinuteClinic and Advocate Health Care Increases Access to Medical Services in Chicagoland 4Ascension Orthopedics Announces TITAN™ Modular Shoulder Implantations at Union Memorial Hospital 2
DCR Set, Angled....
... The Leica CM3050 S Cryostat ... with excellent safety standards for ... applications. The Leica CM3050 S ... for all cryosectioning research applications ...
... The Bright 7500 is a freestanding ... liquid decontamination system and a radial ... to cut a wide range of ... effective for use in high biohazard ...
... - a vision becomes reality. Numerous ... the users many benefits.,The Cryo-Star is ... retraction that incorporates a unique refrigeration ... cooling. This facilitates applications in both ...
Medicine Products: